Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients*
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The role of intensive insulin therapy in medical surgical intensive care patients remains unclear. The objective of this study was to examine the effect of intensive insulin therapy on mortality in medical surgical intensive care unit patients. DESIGN: Randomized controlled trial. SETTINGS: Tertiary care intensive care unit. PATIENTS: Medical surgical intensive care unit patients with admission blood glucose of > 6.1 mmol/L or 110 mg/dL. INTERVENTION: A total of 523 patients were randomly assigned to receive intensive insulin therapy (target blood glucose 4.4-6.1 mmol/L or 80-110 mg/dL) or conventional insulin therapy (target blood glucose 10-11.1 mmol/L or 180-200 mg/dL). MEASUREMENTS AND MAIN OUTCOMES: The primary end point was intensive care unit mortality. Secondary end points included hospital mortality, intensive care unit and hospital length of stay, mechanical ventilation duration, the need for renal replacement therapy and packed red blood cells transfusion, and the rates of intensive care unit acquired infections as well as the rate of hypoglycemia (defined as blood glucose < or = 2.2 mmol/L or 40 mg/dL). There was no significant difference in intensive care unit mortality between the intensive insulin therapy and conventional insulin therapy groups (13.5% vs. 17.1%, p = 0.30). After adjustment for baseline characteristics, intensive insulin therapy was not associated with mortality difference (adjusted hazard ratio 1.09, 95% confidence interval 0.70-1.72). Hypoglycemia occurred more frequently with intensive insulin therapy (28.6% vs. 3.1% of patients; p < 0.0001 or 6.8/100 treatment days vs. 0.4/100 treatment days; p < 0.0001). There was no difference between the intensive insulin therapy and conventional insulin therapy in any of the other secondary end points. CONCLUSIONS: Intensive insulin therapy was not associated with improved survival among medical surgical intensive care unit patients and was associated with increased occurrence of hypoglycemia. Based on these results, we do not advocate universal application of intensive insulin therapy in intensive care unit patients. TRIAL REGISTRATION: Current Controlled Trials registry (ISRCTN07413772) http://www.controlled-trials.com/ISRCTN07413772/07413772; 2005.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overall rate of severe hypoglycemic events in international trials ranged between 5% to 28.6%.3,4,7,8,18,19”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [18]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664 · cited 2×
“nonoperative), history of diabetes, inclusion blood glucose, ICU admission diagnosis and the presence of chronic illnesses using APACHE II definitions (15), vasopressor therapy (defined as the use of any vasopressor infusion except dopamine 5 g/ kg/min), mechanical ventilation, serum creatinine, platelet count, biliru…”
MethodAPACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Because of concerns about trials stopped early for benefit (7), it was suggested that the potential benefits of IIT shown in surgical patients had been inflated (8), thereby causing a premature rush to adopt the therapy (2).”
BackgroundResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862 · cited 1×
“At baseline the following data were recorded: patient’s demographics, weight, height, body mass index (BMI), Acute Physiology and Chronic Health Evaluation (APACHE) II score (15), Sequential Organ Failure Assessment (SOFA) score (16), admission category (postoperative vs.”
MethodPreiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Insulin therapy protects the central and peripheral nervous system of intensive care patients
Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., & Wouters, P. J. (2005) · Neurology · doi:10.1212/01.wnl.0000158442.08857.fc · Cited by 642 · cited 1×
“found that IIT reduced ventilation dependency, intracranial pressure, seizures, and diabetes insipidus, but did not affect mortality (27).”
Background
Research works printed but not linked: 2
- Orford, 2006, Crit Care Resusc, 8, 230
- Devos, 2007, Intensive care Med, 33, S189
Cited by
Items 401–466 of 466
Glycemic control in acute stroke
Kruyt, N. D. (2010)
Endocrine problems in critical illness
Haddara, W. M. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107323919.036
Potential use and limitations of microdialysisfor monitoring of neurochemical changes after TBI
Hillered, L., & Enblad, P. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139030564.008
Tight Glycemic Control in the Neuro-Intensive Care Unit?
Solheim, O. S., & Losvik, O. K. (2012) · Neurosurgery · doi:10.1227/neu.0b013e318282d804
“Several randomized trials were even stopped early owing to serious adverse events.(9,11,12) A large observational trial in more than 10 456 patients before and after the change in practice also failed to demonstrate a survival benefit.”
BackgroundMetabolic monitoring in patients undergoing cardiac surgery using intravascular microdialysis
Schierenbeck, F. (2016) · Figshare
Managing Hyperglycemia in Critically Ill Patients: Where are We Now?
Shoukat, U., Mukhtar, U., & Athar, M. (2016) · JHN journal · doi:10.29046/jhnj.011.1.003
Fuller, J., Granton, J. T., & McConachie, I. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107323919.024
Hyperglycemia in the Surgical Intensive Care Unit
Thiessen, S., Vanhorebeek, I., & den Berghe, G. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-19668-8_36
Tight glucose control using intensive insulin therapy in the critically ill
Seubert, M. E., Khan, S., & Groeneveld, A. B. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511750441.016
Hyperglycemia and Blood Glucose Control
Mesotten, D., & den Berghe, G. V. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00164-6
Should blood glucose be tightly controlled in the intensive care unit?
Lheureux, O., & Preiser, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00034-1
SUNKAUS SEPSIO IR SEPTINIO ŠOKO SUKELTOS ORGANŲ SISTEMŲ DISFUNKCIJOS PREVENCIJA IR GYDYMAS
Gaižauskas, E., Judickas, Š., Balčiūnas, L., Ščupakova, N., Mockutė, L., Šerpytis, M., & Šipylaitė, J. (2016) · Medicinos teorija ir praktika · doi:10.15591/mtp.2016.011
When less is more: the changing paradigm in critical care medicine
Shrestha, G. S. (2016) · Bangladesh Critical Care Journal · doi:10.3329/bccj.v4i2.30017
Pulmonary and Critical Care Updates Update in Critical Care 2008
Fowler, R., Adhikari, N. K. J., Scales, D. C., Lee, W. L., & Rubenfeld, G. D. (2009)
Strict Glycemic Control: The Demise of another Good Strategy?
Panditrao, M. M., & Panditrao, M. M. (2015)
Influence of glycemia on admission for the intensive critical care patient outcome
Rasoamampianina, L., Rafanomezantsoa, T. A., Randriamanantany, Z. A., & Riel, A. M. (2016) · The Journal of Medical Research · doi:10.22271/23957565.2016.v2.i6.002
More Doubts About Tight Glycemic Control in the ICU
Brett, A. S. (2008) · Journal watch · doi:10.1056/jw200812240000002
Stamping out hypoglycemia in a surgical Intensive Care Unit: A multidisciplinary approach
Gerlach, A. T., MacDermott, J., Newton, C. L., Cook, C. H., & Murphy, C. V. (2016) · International Journal of Academic Medicine · doi:10.4103/2455-5568.196866
Ichaï, C., & Preiser, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-64010-5_17 · Cited by 2
Pathophysiology of severe traumatic brain injury and management of intracranial hypertension
Juškys, R., & Hendrixson, V. (2019) · Lietuvos chirurgija · doi:10.15388/lietchirur.2019.18.7
“This led to clinical trials investigating the effectiveness of intensive insulin therapy, but patients in such treatment groups had a higher rate of adverse outcomes, primarily due to frequent hypoglycemic episodes [17, 18].”
How does critical illness alter metabolism?
Nunnally, M., & Piper, G. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00072-9
Insulin therapy in critical illness: the whole story on heated debates and the case
Terashima, H. (2019) · The Japanese Journal of SURGICAL METABOLISM and NUTRITION · doi:10.11638/jssmn.53.6_315
Moghadamyeghaneh, Z., & Stewart, L. (2018) · Gastroenterology · doi:10.1016/s0016-5085(18)34143-x
Yamagiwa, T., Yu, Y., Inoue, Y., Belov, V., Papisov, M. I., Inokuchi, S., Kaneki, M., White, M. F., Fischman, A. J., & Tompkins, R. G. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.09639
“Intensive insulin therapy has been shown to improve glucose homeostasis in burned children(9); however, the increased incidence of hypoglycemic episodes with negative outcomes(1, 4, 17) requires a better understanding of the underlying molecular mechanism(s) of the burn-induced insulin resistance.”
Backgroundvon Gruben, L. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8178
Forty‐Fourth ASPEN Presidential Address: The 2020 Overture—A New Tune for the Future
Chan, L. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2044
Glycaemic Control in Critically Ill Adult Patients: Is intensive insulin therapy beneficial?
Seuradge, C., Chen, D., & Hariharan, S. (2020) · Caribbean Medical Journal · doi:10.48107/cmj.2020.03.001
Ormsbee, J. J., Knopp, J. L., & Chase, J. G. (2020) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2020.12.440
Diabetes Management in Patients with Critical and Non‐Critical Illness
Muthusamy, K., Grdinovac, K., & Miles, J. M. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch20
(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23841-3.00041-2
(2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833643b4
Insulin therapy in the intensive care unit
den Berghe, G. V., Vanwijngaerden, Y.-M., & Mesotten, D. (2011) · doi:10.1093/med/9780199235292.003.1489
Arabi, Y. M. (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110385820
Self-citationIncretin Effects and Enteral Feed Transitions
Jamaludin, U. K., Docherty, P. D., & Preiser, J. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8503-2_157-1
Lin, S., Ge, S., He, W., & Zeng, M. (2020) · Research Square · doi:10.21203/rs.3.rs-55105/v1
Daviaud, F., & Pène, F. (2013) · Références en réanimation · doi:10.1007/978-2-8178-0389-0_16 · Cited by 1
Prescott, P. T. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920660.032
Bistrian, B. R. (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110377339
Effectiveness of tight glycemic control in the medical Intensive Care Unit: a systematic review
Merrill, A., & Jones, S. (2011) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/01938924-201109130-00001
(2017) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12191
Neurologic Manifestations of Acid–Base Derangements, Electrolyte Disorders, and Endocrine Crises
Wijdicks, E. F. M. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197585016.003.0014
Can we Provide Effective Glycemic Control in Intensive Care Unit? Point Prevalence Study
Bílír, Y. (2023) · Southern Clinics of Istanbul Eurasia · doi:10.14744/scie.2023.47568
“[3,14] Two multicenter, randomized controlled trials, VISEP and GLUCONTROL, were terminated due to frequent hypoglycemia.[15,16] In the same period, the results of the NICE-SUGAR study were shared with the literature.”
Resultอัตราการเสียชีวิตที่ 1 ปีของผู้ป่วยโรคหลอดเลือดหัวใจตีบฉับพลันแบบเอสทียกในแต่ละระดับของไขมันแอลดีแอล
หลายชูไทย, ณ. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1261
ประสิทธิภาพและความปลอดภัยของการใช้แบบฟอร์มการปรับอินซูลินในหอผู้ป่วยวิกฤตทางอายุรกรรม
หลายชูไทย, ณ. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1260
Dolan, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4160-2455-2.00015-3
Chen, Y., Lu, L., Liu, B., Deng, X.-M., Zheng, Y., Zeng, Y., Wang, K., Guo, X., Zhou, T., Ye, W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5032021/v1
The Endocrine Response to Critical Illness
Ruiz, J., & Agus, M. S. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_41
Diabetic emergencies and glucose control in the ICU
Ramanan, M., & Ekinci, E. I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11611-7.00068-2
Recent Publications on Medications and Pharmacy
Sterling, J. A. (2008) · Hospital Pharmacy · doi:10.1310/hpj4312-1024
The Neurointensive Care Unit as a Platform for Advanced Clinical Research
Enblad, P., Howells, T., & Hillered, L. (2012) · Springer eBooks · doi:10.1007/978-3-642-28126-6_72
Sun, C., Zhou, J.-H., Huang, Y.-L., Ning, Y.-L., & Xu, X. (2024) · Figshare · doi:10.6084/m9.figshare.25239433
van Hooijdonk, R. T. M., Leopold, J. H., Winters, T., Binnekade, J. M., Juffermans, N. P., Horn, J., Fischer, J., van Dongen-Lases, E. C., & Schultz, M. J. (2021) · Figshare · doi:10.6084/m9.figshare.15094750
Sun, C., Zhou, J.-H., Huang, Y.-L., Ning, Y.-L., & Xu, X.-H. (2024) · Figshare · doi:10.6084/m9.figshare.25239415
Uijtendaal, E. V., Rijkom, J. E. F. Z., de Lange, D. W., Lalmohamed, A., van Solinge, W. W., & Egberts, T. C. G. (2015) · Figshare · doi:10.6084/m9.figshare.4473086
Sun, C., Zhou, J.-H., Huang, Y.-L., Ning, Y.-L., & Xu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26682172
Sun, C., Zhou, J.-H., Huang, Y.-L., Ning, Y.-L., & Xu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26682175
Alruwaili, T. Z., Absher, S. M. T., Alanazi, S. S., El-Malky, A., & Alqahtani, M. M. (2025) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2025.154011
Fenger, A. W., Olsen, M. H., Jensen, H. R., Eskildsen, S. J., Honoré, L. R., Fabritius, M. L., Kondziella, D., Nielsen, S. T., Krogh‐Madsen, R., Riberholt, C. G., et al. (2026) · Neurocritical Care · doi:10.1007/s12028-026-02592-2
Liu, H., Gao, Z., & Zhang, X. (2026) · Statistics and Computing · doi:10.1007/s11222-026-10947-0
Duan, Y., Liu, J., Lin, S., Li, X., Luo, D., & Zhu, L. (2026) · Nursing in Critical Care · doi:10.1111/nicc.70611
Idrees, T., Nalabolu, S., Oladejo, O., Elshimy, G., Orobio, C., & Umpierrez, G. E. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2026-006533 · Cited by 1
Tight glucose control in the post-NICE SUGAR era
Preiser, J. (2009) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
Metadata
- Authors
- Arabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., Kahoul, S. H., Britts, R. J., & Sakkijha, M. H.
- Affiliations
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Venue
- Critical Care Medicine
- Published
- 2008-12
- Volume
- 36
- Issue
- 12
- Pages
- 3190-3197
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2058406121
- Cited by
- 471
- References
- 27
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 14 · 2023: 7 · 2022: 3 · 2021: 12 · 2020: 19 · 2019: 21 · 2018: 23 · 2017: 23 · 2016: 32 · 2015: 39 · 2014: 25 · 2013: 28 · 2012: 41
- FWCI
- 40.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, conventional insulin therapy, glycemic control, critically ill patients, ICU mortality, hypoglycemia, glycemic targets, mechanical ventilation, renal replacement therapy, intensive care unit infections, length of hospital stay, hyperglycemia, sepsis, trauma, neurocritical care
- MeSH terms
- Blood Glucose, Body Weights and Measures, Demography, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Length of Stay, Male, Middle Aged, Postoperative Period, Respiration, Artificial, Surgical Procedures, Operative, Critical Illness, Hospital Mortality, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.